for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised. State-of-the-art treatment of OAB in 1999 includes ...

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

A recent groundbreaking study revealed that an amnion/chorion (AC) bilayer product could treat interstitial cystitis/bladder ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Bladder training is a behavioral treatment that may be effective in eliminating bedwetting (or enuresis) among children. Bladder training seeks to increase the capacity of the bladder and the strength ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

Key Takeaways Men’s incontinence is a common issue affecting many individuals globally. Understanding the types and causes ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).